NeuroHelp Report issue

For profit Phase 2
Founded: Olomouc Czech Republic (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2012
NCT01726413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

grc 17356 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 2)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1